Verastem, Inc. logo

VSTMVerastem, Inc.

VSTM Stock Price, Valuation & Chart | Verastem, Inc.

Compare

VSTM Historical price chart

VSTM Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization704.75M
PE Ratio-3.21
EPS-2.5
Trading Volume5.26M
Today's High/Low8.1/7.68
Dividend Yield0.00
52 Week High/Low11.25/3.43
Shares Outstanding87.87M
VSTM Financial Statement
VSTM Analyst ratings
VSTM Analysis & performance metrics

VSTM Company profile

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development…

VSTM Management team

Management
Cathy Carew
Chief Organizational Effectiveness Officer
Colleen Mockbee
Global Head of Regulatory Affairs & Development
Robert A. Weinberg Ph.D.
Co-Founder & Chair of Scientific Advisory Board
Michael Crowther
Chief Commercial & Strategy Officer
Matthew E. RosCOO
Chief Operating Officer
Daniel CalkinsCFO
Chief Financial Officer
Jonathan Pachter Ph.D.
Chief Scientific Officer
Nate Sanburn
Chief Business Officer
Total 8 executives

VSTM Frequently asked questions

What is Verastem, Inc. (VSTM) Stock Price?

Current stock price of Verastem, Inc. (VSTM) stock is $8.020. The stock price is +5.39% higher in the session. The intraday range can be seen from this page. Volume of Verastem, Inc. (VSTM) stock is 5.26M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Verastem, Inc. (VSTM) stock price going up or down today?

The stock price of Verastem, Inc. (VSTM) can change with earnings, company news, and overall market sentiment. Verastem, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Verastem, Inc. stock expensive at its current price?

Whether Verastem, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VSTM on this page is -3.21. EPS on this page is -2.50. Compare those figures with peers and growth expectations before deciding if the current Verastem, Inc. price is justified.

How has the stock price of Verastem, Inc. (VSTM) performed historically?

Historical performance for Verastem, Inc. (VSTM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VSTM reacted to past earnings and market events.

Should I buy Verastem, Inc. (VSTM) stock, at this price?

Buying Verastem, Inc. (VSTM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.